Skip to content
DraconiticResearch
Search Sources API
186,086 studies31 sourcesUpdated 17 min ago
Peer-reviewedCC BY 4.0Frontiers in Immunology

Hypoxia-driven macrophage heterogeneity in sepsis: single-cell transcriptomic insights into immune reprogramming and therapeutic targeting

  1. 1Department of Critical Care Medicine, The Affiliated Hospital of Qingdao University
  2. 2Department of Neurosurgery, The Affiliated Hospital of Qingdao University
  3. 3Dapartment of Pathology, The Affiliated Hospital of Qingdao University

Abstract

Sepsis is characterized by profound immune dysregulation and metabolic remodeling, yet how hypoxia shapes macrophage-state diversity remains incompletely defined. Here, we integrated single-cell transcriptomic profiles from early- and late-stage sepsis with healthy controls to construct a hypoxia-centered immune atlas. The single-cell landscape identified 103,851 cells across 23 clusters, while hypoxia scoring showed that macrophages displayed the strongest hypoxic activity, particularly in early sepsis. Macrophages were further stratified into low-, intermediate- and high-hypoxic states, revealing a continuous transcriptional gradient rather than discrete subsets. High-hypoxic macrophages exhibited increased CytoTRACE-defined plasticity, occupied intermediate-to-late pseudotime states, and showed enhanced inflammatory and metabolic pathway activation. Cell–cell communication analysis positioned these macrophages as bidirectional signaling hubs, with amplified MIF, CCL, ANNEXIN and IL1-related interactions. Integrated high dimensional Weighted Gene Co-expression Network Analysis (hdWGCNA) and machine-learning analyses identified hypoxia-associated hub genes, among which TIPARP emerged as a key regulator linked to macrophage hypoxic remodeling. TIPARP was preferentially enriched in high-hypoxic macrophages and experimentally validated as responsive to hypoxia and inflammatory stimulation, with knockdown can enhance HIF1A and VEGF induction. Drug-sensitivity prediction further suggested state-specific vulnerabilities of hypoxia-adapted macrophages. Together, these findings define hypoxia as a central determinant of macrophage heterogeneity in sepsis and nominate TIPARP as a candidate target for immunometabolic intervention.

Related

  1. Combined siRNA Targeting IκBα and Stat6 Promotes Macrophage Reprogramming toward Cancer Immunotherapy
    Sezen Gul, Juliette Vergnaud, Qinglin Wang +10
    Molecular PharmaceuticsPeer-reviewedCC BY 4.0Full textProteomics & metabolomicsImmunologyHAL
  2. Integrated Transcriptomic Analysis Identifies a Ferroptosis-Related Gene Signature Underlying Macrophage Heterogeneity and Immune Dysregulation in Rheumatoid Arthritis Synovium
    Houchen Liu, Ruizhuo Zhang
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0General medicineCrossref
  3. Chronic Microcystin-LR Exposure Induces Colorectal Inflammation Associated with Macrophage Infiltration and HIF-1α-Related Glycolytic Reprogramming
    Yan Tang, Xiaodie Zhou, Langyi Li +2
    ToxicsPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  4. Metabolic reprogramming of macrophage-specific transketolase orchestrates angiogenesis in diabetic wounds
    Yuan Xiong, Li Lu, Qipeng Wu +6
    Nature CommunicationsPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicineCrossref
  5. Targeting Metabolic Reprogramming in Cancer: Past, Present, and Future
    Niti Kumari, Surendra K Shukla, Ravi Thakur
    Pharmacology & therapeuticsPeer-reviewedLicence not statedFull textOncologyPMC
BibTeX
@article{yu2026hypoxiadriven,
  title = {{Hypoxia-driven macrophage heterogeneity in sepsis: single-cell transcriptomic insights into immune reprogramming and therapeutic targeting}},
  author = {Yanfei Yu and Zhixing Wang and Yongxing Li and Cai Jing and Xia Li},
  journal = {Frontiers in Immunology},
  year = {2026},
  month = oct,
  doi = {10.3389/fimmu.2026.1941002},
  url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1941002/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Hypoxia-driven macrophage heterogeneity in sepsis: single-cell transcriptomic insights into immune reprogramming and therapeutic targeting
AU  - Yanfei Yu
AU  - Zhixing Wang
AU  - Yongxing Li
AU  - Cai Jing
AU  - Xia Li
PY  - 2026
DA  - 2026/10/27
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.1941002
UR  - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1941002/full
AB  - Sepsis is characterized by profound immune dysregulation and metabolic remodeling, yet how hypoxia shapes macrophage-state diversity remains incompletely defined. Here, we integrated single-cell transcriptomic profiles from early- and late-stage sepsis with healthy controls to construct a hypoxia-centered immune atlas. The single-cell landscape identified 103,851 cells across 23 clusters, while hypoxia scoring showed that macrophages displayed the strongest hypoxic activity, particularly in early sepsis. Macrophages were further stratified into low-, intermediate- and high-hypoxic states, revealing a continuous transcriptional gradient rather than discrete subsets. High-hypoxic macrophages exhibited increased CytoTRACE-defined plasticity, occupied intermediate-to-late pseudotime states, and showed enhanced inflammatory and metabolic pathway activation. Cell–cell communication analysis positioned these macrophages as bidirectional signaling hubs, with amplified MIF, CCL, ANNEXIN and IL1-related interactions. Integrated high dimensional Weighted Gene Co-expression Network Analysis (hdWGCNA) and machine-learning analyses identified hypoxia-associated hub genes, among which TIPARP emerged as a key regulator linked to macrophage hypoxic remodeling. TIPARP was preferentially enriched in high-hypoxic macrophages and experimentally validated as responsive to hypoxia and inflammatory stimulation, with knockdown can enhance HIF1A and VEGF induction. Drug-sensitivity prediction further suggested state-specific vulnerabilities of hypoxia-adapted macrophages. Together, these findings define hypoxia as a central determinant of macrophage heterogeneity in sepsis and nominate TIPARP as a candidate target for immunometabolic intervention.
SN  - 1664-3224
ER  -